Pharma Group Sues to Block Louisiana’s Drug Distribution Law

A Louisiana law regulating drugmakers’ participation in a federal drug discount program causes direct conflict with federal law, according to the leading trade group representing the pharmaceutical industry.

The Pharmaceutical Research and Manufacturers of America, or PhRMA, moved for summary judgment Friday against Louisiana’s Act 358 in the US District Court for the Western District of Louisiana Lafayette Division.

Louisiana’s law prevents drug companies from denying or restricting the acquisition or delivery of a drug under the federal 340B drug pricing program at contract pharmacies. It also restricts pharmacy benefit managers or health insurance issuers from reimbursing a 340B covered ...